These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 24642581
1. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Vester-Andersen MK, Prosberg MV, Jess T, Andersson M, Bengtsson BG, Blixt T, Munkholm P, Bendtsen F, Vind I. Am J Gastroenterol; 2014 May; 109(5):705-14. PubMed ID: 24642581 [Abstract] [Full Text] [Related]
2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J. Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595 [Abstract] [Full Text] [Related]
3. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, Peyrin-Biroulet L, Lerebours E, Colombel JF, Gower-Rousseau C. Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350 [Abstract] [Full Text] [Related]
4. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Nørregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group. Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949 [Abstract] [Full Text] [Related]
5. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. Müller KE, Lakatos PL, Arató A, Kovács JB, Várkonyi Á, Szűcs D, Szakos E, Sólyom E, Kovács M, Polgár M, Nemes É, Guthy I, Tokodi I, Tóth G, Horváth Á, Tárnok A, Csoszánszki N, Balogh M, Vass N, Bódi P, Dezsőfi A, Gárdos L, Micskey E, Papp M, Cseh Á, Szabó D, Vörös P, Veres G, Hungarian IBD Registry Group (HUPIR). J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399 [Abstract] [Full Text] [Related]
6. Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study. Vester-Andersen MK, Vind I, Prosberg MV, Bengtsson BG, Blixt T, Munkholm P, Andersson M, Jess T, Bendtsen F. J Crohns Colitis; 2014 Dec; 8(12):1675-83. PubMed ID: 25154681 [Abstract] [Full Text] [Related]
7. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity. Niewiadomski O, Studd C, Hair C, Wilson J, Ding NS, Heerasing N, Ting A, McNeill J, Knight R, Santamaria J, Prewett E, Dabkowski P, Dowling D, Alexander S, Allen B, Popp B, Connell W, Desmond P, Bell S. J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770 [Abstract] [Full Text] [Related]
9. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study. Nørgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OB, Kjeldsen J. Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582 [Abstract] [Full Text] [Related]
10. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study. Jakobsen C, Bartek J, Wewer V, Vind I, Munkholm P, Groen R, Paerregaard A. Aliment Pharmacol Ther; 2011 Nov; 34(10):1217-24. PubMed ID: 21981762 [Abstract] [Full Text] [Related]
17. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Selinger CP, Andrews JM, Titman A, Norton I, Jones DB, McDonald C, Barr G, Selby W, Leong RW, Sydney IBD Cohort Study Group. Clin Gastroenterol Hepatol; 2014 Apr; 12(4):644-50. PubMed ID: 23707778 [Abstract] [Full Text] [Related]
18. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Abramson O, Altschuler A, Perry GS. Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944 [Abstract] [Full Text] [Related]
19. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease. Abraham NS, Richardson P, Castillo D, Kane SV. Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295 [Abstract] [Full Text] [Related]
20. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis. Niewiadomski O, Studd C, Hair C, Wilson J, McNeill J, Knight R, Prewett E, Dabkowski P, Dowling D, Alexander S, Allen B, Tacey M, Connell W, Desmond P, Bell S. J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692 [Abstract] [Full Text] [Related] Page: [Next] [New Search]